1. Medtech Insight
  2. >>Digital Technologies

Tales From HIMSS23: How HHS Provides Options For Patient Validation And What’s Next For Cyber Regulations

 
• By Hannah Daniel

A series of stories from the Healthcare Information and Management Society's 2023 Global Health Conference.

• Source: LOTUS EYES PHOTOGRAPHY

Healthcare delivery organizations (HDOs) are working on improving patient validation processes. The groups often face challenges due to these slow, clunky processes, and verifying a patient’s identity can take time and slow down the continuum of care for a person who needs to see multiple provides.

A presentation by the CARIN Alliance at HIMSS23 presented a case study of a public-private collaboration that successfully

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Cybersecurity

More from Digital Technologies

Synchron And Apple Team Up To Use ‘Mind-Thought Connection’ To Control iPhones, iPads

 
• By Marion Webb

Apple and Synchron are teaming up to develop technologies that will one day allow people who can’t use their hands or voice to control iPhones, iPads and other Apple devices by using only their thoughts.

Ketryx Wants Its Validated AI Agents To Accelerate Compliance Workflows

 
• By Shubham Singh

While the initial focus is medical devices and life sciences, Ketryx sees future opportunities in other high-regulation sectors including automotive, aerospace and defense, pharma manufacturing and nuclear systems.

Axoft Starts Commercializing Soft BCI-Enabling Materials For R&D Use, Aims To Rewrite BCI Playbook

 
• By Marion Webb

After publishing encouraging results from first-in-human trials of its brain-computer interface, Axoft announced plans to sell its BCI-enabling material Fleuron to researchers and private organizations for R&D use. The company sees this as a revenue stream and feedback loop to refine its BCI platform designed for safer, longer-lasting brain implants.